Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Arch Pediatr ; 17(1): 10-3, 2010 Jan.
Artigo em Francês | MEDLINE | ID: mdl-19932602

RESUMO

3-Hydroxy-3-methylglutaric aciduria is a rare autosomal recessive genetic disorder due to a deficiency of the 3-hydroxy-3-methylglutarylCoA lyase (HMG-CoA lyase), a mitochondrial enzyme involved in ketogenesis and in the final step of l-leucine catabolism. HMG-CoA lyase deficiency can lead, in particular circumstances, such as fever, prolonged fasting or digestive disorders, to brutal and severe hypoglycemia with metabolic acidosis and sometimes fatal coma. We report on a new case of 3-hydroxy-3-methylglutaric aciduria particular by its late onset in a 3-year-old patient. Molecular investigation identified two new sequence modifications in the HMGCL gene: c.494G>A (p.Arg165Gln) and c.820G>A (p.Gly274Arg). We remind about this case report that the therapeutical is mainly preventive and allows a very good prognosis for this disease. Long-term treatment consists in limited fasting time, continuous low protein diet and l-carnitine supplementation. Preventive measures are essential: prevention of fasting and emergency treatment during intercurrent infections.


Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/genética , Aberrações Cromossômicas , Genes Recessivos/genética , Hipoglicemia/genética , Meglutol/urina , Oxo-Ácido-Liases/deficiência , Oxo-Ácido-Liases/genética , Doenças Raras/diagnóstico , Doenças Raras/genética , Alelos , Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Carnitina/administração & dosagem , Pré-Escolar , Terapia Combinada , Análise Mutacional de DNA , Dieta com Restrição de Proteínas , Éxons/genética , Humanos , Hipoglicemia/urina , Leucina/metabolismo , Masculino , Reação em Cadeia da Polimerase , Doenças Raras/terapia , Análise de Sequência de DNA
2.
Arch Pediatr ; 15(8): 1283-8, 2008 Aug.
Artigo em Francês | MEDLINE | ID: mdl-18586472

RESUMO

AIM: To determine the impact of rapid influenza test (RIT) on the prescription of additional tests, antibiotics and oseltamivir, and the influence of oseltamivir on clinical signs and parents' day work stoppage. METHODS: Prospective study in the pediatric emergency department of Nice University Hospital from 29th January 2007 to 3rd March 2007 including children from 1 month to 6 years old with fever greater or equal to 38.5 degrees C for less than 48 h. Virologic research on nasopharyngeal aspiration was: immunofluorescence, cell culture and RIT Quickvue. Clinical informations, additional tests and treatments were registered for each child. An antiviral treatment (oseltamivir) was proposed to children older than 1 year with positive RIT. Evolution at 7 days was evaluated by phone contact. RESULTS: One hundred and seventy-seven children were included (mean age 24 months, sex-ratio 1.88). The RIT was positive in 42.3% (n=75). Compared with cell culture, the sensibility, specificity, positive predictive value and negative predictive value of the RIT were, respectively, 95.6, 91.6, 88 and 97%. Clinical signs significantly correlated to influenza were: impairment, rhinitis and acute otitis media. In the RIT positive group, there were significantly less additional tests (13 versus 36) and particularly urinalysis (5 versus 19), and more spreading in the family (p=0.0002). There was not any significant difference concerning hospitalizations, antibiotic prescriptions, or parents' day work stoppage. CONCLUSION: During influenza epidemic, in a pediatric emergency department, RIT allows a reduction of additional tests in febrile young children, particularly urinalysis.


Assuntos
Alphainfluenzavirus/isolamento & purificação , Betainfluenzavirus/isolamento & purificação , Influenza Humana/diagnóstico , Influenza Humana/epidemiologia , Fatores Etários , Antivirais/uso terapêutico , Criança , Pré-Escolar , Cromatografia/métodos , Interpretação Estatística de Dados , Serviço Hospitalar de Emergência , Feminino , França/epidemiologia , Humanos , Lactente , Recém-Nascido , Influenza Humana/tratamento farmacológico , Influenza Humana/virologia , Masculino , Oseltamivir/uso terapêutico , Estudos Prospectivos , Fatores Sexuais , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA